A Phase I Trial of Venetoclax in Combination With BEAM Conditioning Regimen for Autologous Stem Cell Transplantation in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Phase of Trial: Phase I
Latest Information Update: 07 Jan 2020
Price : $35 *
At a glance
- Drugs Venetoclax (Primary) ; Carmustine; Cytarabine; Etoposide; Melphalan
- Indications Non-Hodgkin's lymphoma; T-cell lymphoma
- Focus Adverse reactions
- 24 Jun 2019 Status changed from recruiting to suspended.
- 08 Jan 2019 Status changed from not yet recruiting to recruiting.
- 25 Oct 2018 New trial record